A

ATAI Life Sciences NV
D

ATAI

6.01000
USD
0.62
(11.40%)
مفتوح الان
حجم التداول
248,215
الربح لكل سهم
-0
العائد الربحي
-
P/E
-9
حجم السوق
1,405,014,194
الأخبار المقالات

العنوان: ATAI Life Sciences NV

القطاع: Healthcare
الصناعة: Biotechnology
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.